Physical Capacity in Hodgkin Lymphoma Survivors

NCT04636255 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2026-05-04

No results posted yet for this study

Summary

The study aims to investigate if physical capacity obtained in the cardiopulmonary exercise test can predict cardiovascular alterations in Hodgkin Lymphoma (HL) Survivors. In addition, to study the effects of exercise training on physical capacity and cardiovascular responses in these patients.

Conditions

Interventions

PROCEDURE

Physical Characteristics

Body Weight, Height

DIAGNOSTIC_TEST

Assessment of Heart rate variability

Holter 24h

DIAGNOSTIC_TEST

Blood Pressure and Cardiac Autonomic Control

Non-invasive photoplethysmography (Finometer® PRO) monitored by the electrocardiogram and respiratory frequency by a piezoelectric chest strap.

DIAGNOSTIC_TEST

Evaluation of Baroreflex Control

The magnitude and latency of the baroreflex control of the heart rate will be assessed by bivariate analysis using the autoregressive method.

DIAGNOSTIC_TEST

Cardiac Function and Structure

Echocardiogram

DIAGNOSTIC_TEST

Assessment of Coronary Anatomy and Calcium Score

Angiotomography

DIAGNOSTIC_TEST

Blood Assessments

Serum and Plasma will be extracted by centrifugation. NT-pro BNP (Roche™) and c-TnI (imunoassay Elecys 2010).

DIAGNOSTIC_TEST

Physical Capacity

Cardiopulmonary Exercise Test.

PROCEDURE

Physical Training

Aerobic exercise: 48 sessions of 60 minutes: 5 minutes of warm-up, 40 minutes of exercise. Resistance exercise: 10 minutes of exercise and 5 minutes of recovery.

Sponsors & Collaborators

  • University of Sao Paulo General Hospital

    lead OTHER

Principal Investigators

  • Carlos E Negrao, PhD · Instituto do Coracao, HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-10-21
Primary Completion
2022-10-21
Completion
2023-10-21

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04636255 on ClinicalTrials.gov